Podcasts · Science

Lung Cancer Considered

IASLC

300 episodes

Dr. Stephen Liu and Dr. Narjust Florez host Lung Cancer Considered, the podcast of The International Association for the Study of Lung Cancer (IASLC). IASLC is the only global organization dedicated solely to the study of lung cancer and other thoracic malignancies. Founded in 1974, the association's membership includes more than 11,000 lung cancer specialists across all disciplines in over 100 countries, forming a global network working together to conquer lung and thoracic cancers worldwide. The association also publishes the Journal of Thoracic Oncology, the primary educational and informational publication for topics relevant to the prevention, detection, diagnosis and treatment of all thoracic malignancies. Visit www.iaslc.org for more information.

More about the show

Lung Cancer considered is funded in part by Current sponsors: • AbbVie • AstraZeneca • Gilead • J&J • Summit

Episodes page 2 of 6

  1. Lung Cancer Considered: Lung Cancer Care in Areas of Conflict and War

    · 48 min

    This episode of Lung Cancer Considered, hosted by Dr. Narjust Florez, examines the challenges of delivering lung cancer care in areas affected by war and displacement with guests Dr. Julie Gralow and Dr. Rafal…

  2. LCC in Turkish: Virtual Tumor Board Immunotherapy for NSCLC

    · 37 min

    As part of IASLC’s ongoing series of Lung Cancer Considered podcast episodes in world languages, Dr. Ece Cali moderates a discussion in Turkish with Dr. Irfan Çiçin and Dr. Fulden Yumuk. The episode is part of our…

  3. Lung Cancer Considered: IASLC Hot Topic in Basic & Translational Science Meeting Highlights

    · 36 min

    This episode reviews the IASLC 2025 Hot Topic in Basic and Translational Science Conference, which focused on unraveling precancer and early-stage lung cancer, a theme that really captures where the field is heading.…

  4. Lung Cancer Considered in Portuguese: Junior Faculty Perspective

    · 45 min

    As part of IASLC’s Lung Cancer Considered World Language Series, guest host Dr. Maria Cecilia Mathias leads a discussion in Portuguese about the junior faculty perspective with Dr. Maria Thereza Starling and Dr. Paula…

  5. Lung Cancer Considered: Role of General Media in Lung Cancer Research

    · 31 min

    In this episode of Lung Cancer Considered, host Dr. Stephen Liu is joined by CNN Medical Correspondent Meg Tirrell and WTOP reporter Neal Augenstein to discuss the role of the media in lung cancer awareness and…

  6. Lung Cancer Considered -- Immunotherapy Toxicity: Myths & Pearls

    · 19 min

    Since the first immunotherapy agent for lung cancer was approved in 2015, this class of drugs has captured the imagination and the narrative for the treatment of driver negative lung cancer. Immunotherapy is now the…

  7. Lung Cancer Considered: A New Shot at Progress: Amivantamab Goes SubQ

    · 36 min

    The FDA has approved subcutaneous amivantamab. Join host Dr. Narjust Florez and guests, Dr. Natasha Leighl and Dr. Federico Cappuzzo, as they explore the science and convenience factor, as well as what this shift means…

  8. Lung Cancer Considered at the ASCO IASLC 2025 North American Conference on Lung Cancer

    · 38 min

    In this special episode of Lung Cancer Considered, Dr. Narjust Florez and Dr. Stephen Liu discuss highlights from the IASLC | ASCO 2025 North America Conference on Lung Cancer. Dr. Igor Odintsov discusses updates in…

  9. Lung Cancer Care in New Zealand

    · 25 min

    In this episode of Lung Cancer Considered, host Dr. Stephen Liu speaks with two thoracic oncologists practicing in New Zealand—Dr. Laird Cameron from Auckland Hospital and Dr. Annie Wong from the University of…

  10. LCC in Spanish: Mujeres and oncologia toracica – Latinoamerica

    · 48 min

    As part of IASLC’s Lung Cancer Considered World Language Series, host Dr. Narjust Florez leads a Spanish-language discussion with three leaders in thoracic oncology across Latin America: Dr. Mónica Castro, Dr. Dolores…

  11. IASLC Lung Cancer Considered: ADCs in EGFR Mutant NSCLC

    · 36 min

    In this episode of Lung Cancer Considered, host Dr. Stephen Liu speaks with Prof. Li Zhang and Dr. Elaine Shum about recent progress in antibody–drug conjugates (ADCs) for EGFR-mutant non-small cell lung cancer…

  12. Can I Take That? Integrative Medicine and Lung Cancer

    · 45 min

    Join Dr. Narjust Florez as she explores complementary and integrative medicine in lung cancer care with leading experts Dr. Ting Bao, Dr. Jun J. Mao, and Dr. Lisa Davis. This episode clarifies the differences between…

  13. LCC in Spanish: ¿Pulmón Vital: donde la ciencia se encuentra con la medicina tradicional

    · 51 min

    As part of IASLC’s Lung Cancer Considered world language series, host Dr. Narjust Florez discusses the role of complementary medicine in cancer care in Spanish with Dr. Cittim Bernardo Palomares and Dr. Eduardo…

  14. LCC in Georgian: WCLC 2025 Highlights

    · 31 min

    The 2025 World Conference on Lung Cancer brings together leading experts, researchers, and oncologists to showcase the latest advancements in lung cancer research. To reach a global audience, IASLC has recorded podcast…

  15. The New Face of Lung Cancer: A Conversation with Two Young Lung Cancer Warriors

    · 44 min

    In this episode of Lung Cancer Considered, host Dr. Narjust Florez speaks with two remarkable young lung cancer advocates Samantha Murell and Megan Flanagan, who are redefining what it means to live with the disease.…

  16. LCC in Hungarian: WCLC 2025 Highlights

    · 1 h 01 min

    The 2025 World Conference on Lung Cancer brings together leading experts, researchers, and oncologists to showcase the latest advancements in lung cancer research. To reach a global audience, IASLC has recorded podcast…

  17. IASLC Lung Cancer Considered: ESMO 2025 Highlights

    · 38 min

    This episode of Lung Cancer Considered covers highlights from the 2025 ESMO Annual Meeting held October 17th to the 21st in Berlin, Germany. Guests are: Dr. Xiuning Le from MD Anderson Cancer Center in Houston, Texas.…

  18. Lung Cancer Considered: • Rising Above: The Lung Cancer Hope Summit

    · 46 min

    In this episode of Lung Cancer Considered, Dr. Narjust Florez leads a discussion with Ann Fish-Steagall and Amanda Nerstad about the 2025 Lung Cancer Hope Summit. The team discusses highlights from the meeting,…

  19. LCC in Greek: WCLC 2025 Highlights

    · 54 min

    The 2025 World Conference on Lung Cancer brings together leading experts, researchers, and oncologists to showcase the latest advancements in lung cancer research. To reach a global audience, IASLC has recorded podcast…

  20. FDA Approval: Maintenance Lurbinectedin for SCLC

    · 38 min

    In this episode of Lung Cancer Considered, host Dr. Stephen Liu discusses the recent FDA approval of maintenance lurbinectedin plus atezolizumab for extensive stage small cell lung cancer, based on the phase III…

  21. LCC in Arabic: WCLC 2025 Highlights

    · 25 min

    The 2025 World Conference on Lung Cancer brings together leading experts, researchers, and oncologists to showcase the latest advancements in lung cancer research. To reach a global audience, IASLC has recorded podcast…

  22. Lung Cancer Considered in Dutch: Targeting EGFR NSCLC

    · 44 min

    As part of IASLC’s ongoing series of Lung Cancer Considered podcasts in world languages, Dr. Lizza Hendriks moderates a discussion in Dutch with Dr. Marthe Paats and Dr. Gerrina Ruiter on the treatment of EGFR…

  23. Lung Cancer Considered: Targeting EGFR NSCLC

    · 44 min

    Lung Cancer Considered: Targeting EGFR NSCLC by IASLC

  24. Lung Cancer Considered in Japanese---2025 WCLC Highlights

    · 35 min

    The 2025 World Conference on Lung Cancer brings together leading experts, researchers, and oncologists to showcase the latest advancements in lung cancer research. To reach a global audience, IASLC has recorded podcast…

  25. LCC in Korean: WCLC 2025 Highlights

    · 20 min

    The 2025 World Conference on Lung Cancer brings together leading experts, researchers, and oncologists to showcase the latest advancements in lung cancer research. To reach a global audience, IASLC has recorded podcast…

  26. IASLC Lung Cancer Considered: FDA Approval: Subcutaneous Immunotherapy

    · 46 min

    This episode of Lung Cancer Considered reviews new and upcoming approvals for subcutaneous immune checkpoint inhibitors. Join host Dr. Narjust Florez and guests, Dr. Cheryl Ho and Dr. Maria Velez Velez, for a…

  27. LCC in Mandarin: WCLC 2025 Highlights with Experts from Taiwan

    · 50 min

    The 2025 World Conference on Lung Cancer brings together leading experts, researchers, and oncologists to showcase the latest advancements in lung cancer research. To reach a global audience, IASLC has recorded podcast…

  28. LCC in Portuguese: WCLC 2025 Highlights

    · 43 min

    The 2025 World Conference on Lung Cancer brings together leading experts, researchers, and oncologists to showcase the latest advancements in lung cancer research. To reach a global audience, IASLC has recorded podcast…

  29. LCC in Spanish: WCLC 2025 Through a Junior Faculty Lens

    · 23 min

    In this episode, recorded live in Spanish at WCLC 2025, Dr. Diego Carrillo reflects on his experiences as a junior faculty member at WCLC 2025. In conversation with host Dr. Narjust Florez, they discuss conference…

  30. LCC in Hebrew: WCLC 2025 Highlights

    · 20 min

    The 2025 World Conference on Lung Cancer brings together leading experts, researchers, and oncologists to showcase the latest advancements in lung cancer research. To reach a global audience, IASLC has recorded podcast…

  31. Live From WCLC 2025: Tuesday Highlights & Meeting Summary

    · 44 min

    In this special WCLC 2025 episode of Lung Cancer Considered, hosts Dr. Narjust Florez and Dr. Stephen Liu discuss highlights from the conference. Dr. Susan Scott discusses EGFR mutant NSCLC and results from PALOMA-2…

  32. LCC in Spanish: WCLC 2025 Highlights

    · 40 min

    The 2025 World Conference on Lung Cancer brings together leading experts, researchers, and oncologists to showcase the latest advancements in lung cancer research. To reach a global audience, IASLC has recorded podcast…

  33. Live From WCLC 2025: Monday Highlights

    · 42 min

    In this special WCLC 2025 episode of Lung Cancer Considered, hosts Dr. Narjust Florez and Dr. Stephen Liu discuss daily highlights from the conference. Dr. Tina Cascone discusses results from the NADIM ADJUVANT Phase…

  34. LCC in Mandarin: WCLC 2025 Highlights

    · 36 min

    The 2025 World Conference on Lung Cancer brings together leading experts, researchers, and oncologists to showcase the latest advancements in lung cancer research. To reach a global audience, IASLC has recorded podcast…

  35. Live From WCLC 2025: Sunday Highlights

    · 24 min

    In this special WCLC 2025 episode of Lung Cancer Considered, hosts Dr. Narjust Florez and Dr. Stephen Liu discuss daily highlights from the conference. Dr. David Planchard discusses the data that we all were waiting…

  36. "I'm in Barcelona, Now What?" — Tips for First-Time WCLC Attendees

    · 19 min

    In this episode of Lung Cancer Considered, Dr. Narjust Florez and Dr. Stephen Liu share tips for first-time attendees of the World Conference on Lung Cancer (WCLC). Recorded live at WCLC 2025, hear their 10 key…

  37. LCC in Mandarin: Neoadjuvant and Perioperative Therapy for Locally Advanced NSCLC

    · 52 min

    LCC in Mandarin: Neoadjuvant and Perioperative Therapy for Locally Advanced NSCLC by IASLC

  38. IASLC - ALK Positive Summit

    · 38 min

    IASLC - ALK Positive Summit by IASLC

  39. LCC in Greek: Virtual Tumor Board - ALK NSCLC

    · 1 h 01 min

    LCC in Greek: Virtual Tumor Board - ALK NSCLC by IASLC

  40. Lung Cancer Considered--STK11 and KEAP1 as resistance mechanisms to immunotherapy

    · 53 min

    Lung Cancer Considered--STK11 and KEAP1 as resistance mechanisms to immunotherapy by IASLC

  41. LCC in Cantonese: Novel Treatment for Advanced EGFR Mutant Lung Cancer

    · 1 h 05 min

    LCC in Cantonese: Novel Treatment for Advanced EGFR Mutant Lung Cancer by IASLC

  42. FDA Approval: Zongertinib for HER2 Mutant NSCLC

    · 42 min

    FDA Approval: Zongertinib for HER2 Mutant NSCLC by IASLC

  43. LCC in Arabic: Arab Women's Voices in Thoracic Oncology

    · 34 min

    As part of IASLC’s ongoing series of podcasts in world languages, Dr. Nagla Abdel Karim moderates a discussion in Arabic with Dr. Asrar AlAhmadi and Dr. Maya Khalil. The group discusses the journey and career…

  44. Artificial Intelligence (AI) and Lung Cancer Treatment Decisions

    · 46 min

    Artificial Intelligence (AI) and Lung Cancer Treatment Decisions by IASLC

  45. Artificial Intelligence (AI) and Lung Cancer Treatment Decisions

    · 46 min

    Artificial Intelligence (AI) and Lung Cancer Treatment Decisions by IASLC

  46. LCC in Romanian: Management of Unresectable, EGFR-mutated Stage III Lung Cancer in Romania

    · 47 min

    LCC in Romanian: Management of Unresectable, EGFR-mutated Stage III Lung Cancer in Romania by IASLC

  47. IASLC - Stigma

    · 57 min

    IASLC - Stigma by IASLC

  48. LCC in Japanese: ASCO 2025 Highlights

    · 34 min

    LCC in Japanese: ASCO 2025 Highlights by IASLC

  49. Preview: IASLC | ASCO 2025 North American Conference on Lung Cancer

    · 23 min

    On December 5, 2025, we will kick off the IASLC ASCO 2025 North America Conference on Lung Cancer. Guest include Dr. Ramesh Rengan, the Peter Wootton Professor and Chair of Radiation Oncology at the University of…

  50. FDA Approval: Datopotamab Deruxtecan for EGFR NSCLC

    · 46 min

    FDA Approval: Datopotamab Deruxtecan for EGFR NSCLC by IASLC

Shows are listed from Apple Podcasts' charts and directory, and Podcast Index where it is used. Every show and episode belongs to its publisher and plays from the publisher's own feed; this site hosts none of them. Explicit shows are for adult profiles only, and children’s profiles hear only children’s shows. More about this list.